Old Web
English
Sign In
Acemap
>
Paper
>
PO-1182: PSMA-PET is superior to choline-PET based SABR for ADT deferral in oligometastatic prostate cancer
PO-1182: PSMA-PET is superior to choline-PET based SABR for ADT deferral in oligometastatic prostate cancer
2020
C. Deijen
G.L. Vrijenhoek
Wouter V. Vogel
Luc M.F. Moonen
Floris J. Pos
H.G. van der Poel
G. Borst
Keywords:
Prostate cancer
Oncology
Medicine
psma pet
SABR volatility model
choline pet
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]